According to our (Global Info Research) latest study, the global Medical Biological Protein Glue market size was valued at US$ 527 million in 2025 and is forecast to a readjusted size of US$ 766 million by 2032 with a CAGR of 5.6% during review period.
In 2025, the global production of medical biological protein glue was 3.3 million units, with an average price of US$147.5 per unit, with a gross profit margin typically between 45% and 65%.
Medical bio-protein glue is a special functional adhesive used in medicine. Its main components typically include functions such as hemostasis, promoting tissue healing, sealing wounds, and preventing adhesions. It is widely used in surgical procedures and wound care, and its mechanism of action is to assist in tissue repair by forming a gel-like substance.
Medical bio-protein glues consist of upstream components such as plasma proteins, fibrinogen, thrombin, lyophilized human or animal-derived protein components, recombinant protein materials, medical buffer solutions, stabilizers, and aseptic filling and lyophilization packaging systems. These raw materials determine its gelation speed, tensile strength, wet adhesion properties, and tissue compatibility. Downstream applications are mainly concentrated in surgical hemostasis, neurosurgical dural repair, thoracic pulmonary leak sealing, cardiovascular effusion control, closure of cut surfaces of hepatobiliary and pancreatic parenchymal organs, and plastic and reconstructive adhesive grafting and fixation. Among these, parenchymal organ resection, complex cardiothoracic surgeries, and neurosurgical dural repair are the fastest-growing segments. Bio-protein adhesives can rapidly solidify in a moist environment during surgery, replacing some sutures and patches, significantly reducing intraoperative bleeding and postoperative leakage rates, and shortening surgical time. Therefore, their penetration rate is significantly improved in high-risk, minimally invasive, and difficult-to-suture tissue scenarios.
Global development trends focus on faster solidification, higher adhesion strength, lower immune response, controllable degradation, and the use of smaller quantities but with stronger effects through high-concentration two-component formulations. Driving factors include the increased difficulty in suturing due to the rising proportion of minimally invasive surgeries, the increased reliance on rapid hemostatic materials due to the rise in high-risk surgeries caused by an aging population, hospitals' higher requirements for intraoperative time and complication control, surgeons' increased preference for predictable hemostatic effects, and the standardization of regulations on high-grade biomaterials driving the penetration of high-quality products. Obstacles mainly stem from the high cost of upstream raw materials such as plasma due to supply constraints, strict regulatory requirements and long certification cycles for human-derived protein products in different countries, ethical and immunological risks associated with animal-derived materials in some markets, insufficient adhesion stability of some products in high-flow-rate blood vessels or high-tension tissues, and hospitals' budget sensitivity to high-priced bioadhesives.
This report is a detailed and comprehensive analysis for global Medical Biological Protein Glue market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Biological Protein Glue market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Biological Protein Glue market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Biological Protein Glue market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Biological Protein Glue market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Biological Protein Glue
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Biological Protein Glue market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter International, Johnson & Johnson (Ethicon), CSL Behring, Grifols, Pfizer, Takeda Pharmaceutical Company, B. Braun Melsungen, BD, Corza Medical, Tissuemed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Biological Protein Glue market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Animal Source
Human Source
Recombinant Human Source
Compound Source
Market segment by Function
Hemostatic Type
Tissue Adhesive Type
Wound Repair Type
Sealing Type
Market segment by Degradation Cycle
1-2 Weeks
3-6 Weeks
6-12 Months
1-6 Months
Market segment by Form
Gel
Spray
Injection
Sponge/Membrane
Market segment by Application
Neurosurgery
Cardiovascular Surgery
Orthopedics
Dermatology
Others
Major players covered
Baxter International
Johnson & Johnson (Ethicon)
CSL Behring
Grifols
Pfizer
Takeda Pharmaceutical Company
B. Braun Melsungen
BD
Corza Medical
Tissuemed
Medtronic
Integra LifeSciences Corporation
The Medicines Company
Stryker Corporation
Vivostat
Nordson Medical
Hemarus Therapeutics
C.R. Bard
Z-Medica
LifeBond
Pharming Group
Harvest Technologies
KM Biologics
STB Lifesaving Technologies
Asahi Kasei Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Biological Protein Glue product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Biological Protein Glue, with price, sales quantity, revenue, and global market share of Medical Biological Protein Glue from 2021 to 2026.
Chapter 3, the Medical Biological Protein Glue competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Biological Protein Glue breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Biological Protein Glue market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Biological Protein Glue.
Chapter 14 and 15, to describe Medical Biological Protein Glue sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Medical Biological Protein Glue. Industry analysis & Market Report on Medical Biological Protein Glue is a syndicated market report, published as Global Medical Biological Protein Glue Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Biological Protein Glue market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.